Claim being checked · Version 1 · Reviewed
“BPC-157 improves tendon healing in preclinical models.”
Written and source-checked by Anthony Treviso, founder of The Peptide Field.
No dosing advice. This guide explains research. It was not independently medically reviewed, and it does not diagnose, prescribe, or recommend treatment.
Supported with scope. The reviewed evidence supports this exact statement only in the situation described below.
Answer scope
This verdict checks the exact claim in the heading. It is not a universal grade for BPC-157.
01 · Answer
Supported with scope
Cell and rat tendon studies report positive healing signals. The scope matters: these results support biological plausibility, not a proven human treatment.
- What kind of evidence this is
- Preclinical evidence. This answer uses research in cells, animals, or other settings outside patient care. It does not show a benefit in people.
- What this answer covers
- Cell and animal tendon models only; not clinical healing outcomes in people. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
- Question type
- Performance and recovery. What research does or does not show about physical performance or recovery.
02 · Sources
Read the sources behind this answer
- Editorial review
- Internal editorial review recorded
- Source review
- Anthony Treviso · Founder and responsible editor
- Medical review status
- Not independently medically reviewed. Editorial source review does not replace medical review.